DOI QR코드

DOI QR Code

Purification and Characterization of a Thrombolytic Enzyme Produced by a New Strain of Bacillus subtilis

  • Frias, Jorge (CBA - Biotechnology Centre of Azores, Faculty of Sciences and Technology, University of Azores) ;
  • Toubarro, Duarte (CBA - Biotechnology Centre of Azores, Faculty of Sciences and Technology, University of Azores) ;
  • Fraga, Alexandra (ICVS - Life and Health Research Institute, University of Minho) ;
  • Botelho, Claudia (CEB - Centre of Biological Engineering, University of Minho) ;
  • Teixeira, Jose (CEB - Centre of Biological Engineering, University of Minho) ;
  • Pedrosa, Jorge (ICVS - Life and Health Research Institute, University of Minho) ;
  • Simoes, Nelson (CBA - Biotechnology Centre of Azores, Faculty of Sciences and Technology, University of Azores)
  • Received : 2020.08.06
  • Accepted : 2020.11.02
  • Published : 2021.02.28

Abstract

Fibrinolytic enzymes with a direct mechanism of action and safer properties are currently requested for thrombolytic therapy. This paper reports on a new enzyme capable of degrading blood clots directly without impairing blood coagulation. This enzyme is also non-cytotoxic and constitutes an alternative to other thrombolytic enzymes known to cause undesired side effects. Twenty-four Bacillus isolates were screened for production of fibrinolytic enzymes using a fibrin agar plate. Based on produced activity, isolate S127e was selected and identified as B. subtilis using the 16S rDNA gene sequence. This strain is of biotechnological interest for producing high fibrinolytic yield and consequently has potential in the industrial field. The purified fibrinolytic enzyme has a molecular mass of 27.3 kDa, a predicted pI of 6.6, and a maximal affinity for Ala-Ala-Pro-Phe. This enzyme was almost completely inhibited by chymostatin with optimal activity at 48℃ and pH 7. Specific subtilisin features were found in the gene sequence, indicating that this enzyme belongs to the BPN group of the S8 subtilisin family and was assigned as AprE127. This subtilisin increased thromboplastin time by 3.7% (37.6 to 39 s) and prothrombin time by 3.2% (12.6 to 13 s), both within normal ranges. In a whole blood euglobulin assay, this enzyme did not impair coagulation but reduced lysis time significantly. Moreover, in an in vitro assay, AprE127 completely dissolved a thrombus of about 1 cc within 50 min and, in vivo, reduced a thrombus prompted in a rat tail by 11.4% in 24 h compared to non-treated animals.

Keywords

References

  1. WHO. 2016. Cardiovascular diseases (CVDs). Cardiovascular diseases (CVDs).
  2. Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, et al. 2014. Thrombosis: a major contributor to global disease burden. Arterioscler. Thromb. Vasc. Biol. 34: 2363-2371. https://doi.org/10.1161/ATVBAHA.114.304488
  3. Lopez-Sendon J, Lopez de Sa E, Bobadilla JF, Rubio R, Bermejo J, Delcan JL. 1995. [Cardiovascular pharmacology (XIII). The efficacy of different thrombolytic drugs in the treatment of acute myocardial infarct]. Rev. Esp. Cardiol. 48: 407-439.
  4. Mine Y, Kwan Wong AH, Jiang B. 2005. Fibrinolytic enzymes in Asian traditional fermented foods. Food Res. Int. 38: 243-250. https://doi.org/10.1016/j.foodres.2004.04.008
  5. Duffy M. 2002. Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies. Clin. Chem. 48: 1194-1197. https://doi.org/10.1093/clinchem/48.8.1194
  6. Collen D, Lijnen H. 2004. Tissue-type plasminogen activator: a historical perspective and personal account. J. Thromb. Haemost. 2: 541-546. https://doi.org/10.1111/j.1538-7933.2004.00645.x
  7. Kunamneni A, Abdelghani TT, Ellaiah P. 2007. Streptokinase--the drug of choice for thrombolytic therapy. J. Thromb. Thrombolysis 23: 9-23. https://doi.org/10.1007/s11239-006-9011-x
  8. Murakami K, Yamanaka N, Ohnishi K, Fukayama M, Yoshino M. 2012. Inhibition of angiotensin I converting enzyme by subtilisin NAT (nattokinase) in natto, a Japanese traditional fermented food. Food Funct. 3: 674-678. https://doi.org/10.1039/c2fo10245e
  9. Medved L, Nieuwenhuizen W. 2003. Molecular mechanisms of initiation of fibrinolysis by fibrin. Thromb. Haemost. 89: 409-419. https://doi.org/10.1267/THRO03030409
  10. Kumar A, Pulicherla KK, Ram KS, Rao KRSS. 2010. Evolutionary Trend of Thrombolytics. 2: 18.
  11. Cai D, Zhu C, Chen S. 2017. Microbial production of nattokinase: current progress, challenge and prospect. World J. Microbiol. Biotechnol. 33: 84. https://doi.org/10.1007/s11274-017-2253-2
  12. Kotb E. 2012. Fibrinolytic Bacterial Enzymes with Thrombolytic Activity, pp. 1-74. Fibrinolytic Bacterial Enzymes with Thrombolytic Activity, Ed. Springer Berlin Heidelberg,
  13. Kotb E. 2013. Activity assessment of microbial fibrinolytic enzymes. Appl. Microbiol. Biotechnol. 97: 6647-6665. https://doi.org/10.1007/s00253-013-5052-1
  14. Matseliukh OV, Nidialkova NA, Varbanets LD. 2012. [Purification and physicochemical properties of Bacillus thuringiensis IMB B-7324 peptidase with elastolytic and fibrinolytic activity]. Ukr. Biokhim. Zh. (1999). 84: 25-36.
  15. Nidialkova NA, Matseliukh OV, Varbanets LD. 2013. [Physico-chemical properties of Bacillus thuringiensis IMV B-7324 fibrinolytic peptidase]. Mikrobiol. Z. 75: 3-7.
  16. Nidialkova NA, Matseliukh OV, Varbanets LD. 2012. [Isolation of Bacillus thuringiensis IMV B-7324 fibrinolytic peptidase]. Mikrobiol. Z. 74: 9-15.
  17. Kumar DJM, Rakshitha R, Vidhya MA, Jennifer PS, Prasad S, Kumar MR, et al. 2014. Production, optimization and characterization of fibrinolytic enzyme by Bacillus subtilis RJAS19. Pak. J. Biol. Sci. 17: 529-534. https://doi.org/10.3923/pjbs.2014.529.534
  18. Anh DBQ, Mi NTT, Huy DNA, Hung PV. 2015. Isolation and optimization of growth condition of Bacillus sp. from fermented shrimp paste for high fibrinolytic enzyme production. Arab. J. Sci. Eng. 40: 23-28. https://doi.org/10.1007/s13369-014-1506-8
  19. Lapsongphon N, Rodtong S, Yongsawatdigul J. 2013. Spent brewery yeast sludge as a single nitrogen source for fibrinolytic enzyme production of Virgibacillus sp. SK37. Food Sci. Biotechnol. 22: 71-78. https://doi.org/10.1007/s10068-013-0010-3
  20. Afifah DN, Sulchan M, Syah D, Yanti n, Suhartono MT, Kim JH. 2014. Purification and characterization of a fibrinolytic enzyme from Bacillus pumilus 2.g isolated from Gembus, an Indonesian fermented food. Prev. Nutr. Food Sci. 19: 213-219. https://doi.org/10.3746/pnf.2014.19.3.213
  21. Jeong S-J, Heo K, Park JY, Lee KW, Park J-Y, Joo SH, et al. 2015. Characterization of AprE176, a fibrinolytic enzyme from Bacillus subtilis HK176. J. Microbiol. Biotechnol. 25: 89-97. https://doi.org/10.4014/jmb.1409.09087
  22. Vijayaraghavan P, Arun A, Vincent SGP, Arasu MV, Al-Dhabi NA. 2016. Cow dung is a novel feedstock for fibrinolytic enzyme production from newly isolated Bacillus sp. IND7 and its application in in vitro clot lysis. Front. Microbiol. 7: 361. https://doi.org/10.3389/fmicb.2016.00361
  23. Cho IH, Choi ES, Lim HG, Lee HH. 2004. Purification and characterization of six fibrinolytic serine-proteases from earthworm Lumbricus rubellus. J. Biochem. Mol. Biol. 37: 199-205.
  24. Peng Y, Yang X, Zhang Y. 2005. Microbial fibrinolytic enzymes: an overview of source, production, properties, and thrombolytic activity in vivo. Appl. Microbiol. Biotechnol. 69: 126-132. https://doi.org/10.1007/s00253-005-0159-7
  25. Choi NS, Chung DM, Ryu CR, Yoon KS, Maeng PJ, Kim SH. 2006. Identification of three extracelllar proteases from Bacillus subtilis KCTC 3014. J. Microbiol. Biotechnol. 16: 457-464.
  26. Kamiya S, Hagimori M, Ogasawara M, Arakawa M. 2010. In vivo evaluation method of the effect of nattokinase on carrageenan-induced tail thrombosis in a rat model. Acta Haematol. 124: 218-224. https://doi.org/10.1159/000321518
  27. Xu J, Du M, Yang X, Chen Q, Chen H, Lin D-H. 2014. Thrombolytic effects in vivo of nattokinase in a carrageenan-induced rat model of thrombosis. Acta Haematol. 132: 247-253. https://doi.org/10.1159/000360360
  28. Fujita M, Hong K, Ito Y, Fujii R, Kariya K, Nishimuro S. 1995. Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat. Biol. Pharm. Bull. 18: 1387-1391. https://doi.org/10.1248/bpb.18.1387
  29. Marder VJ, Jahan R, Gruber T, Goyal A, Arora V. 2010. Thrombolysis with plasmin: implications for stroke treatment. Stroke 41: S45-49. https://doi.org/10.1161/STROKEAHA.110.595157
  30. Wang M, Yang W, Wu Q, Gu H. 2012. Modeling of the fibrin agarose plate assay and its application for thrombolytic analysis. Chin. Sci. Bull. 57: 3233-3238. https://doi.org/10.1007/s11434-012-5297-6
  31. Salazar AM, Rodriguez-Acosta A, Giron ME, Aguilar I, Guerrero B. 2007. A comparative analysis of the clotting and fibrinolytic activities of the snake venom (Bothrops atrox) from different geographical areas in Venezuela. Thromb. Res. 120: 95-104. https://doi.org/10.1016/j.thromres.2006.07.004
  32. Smith AA, Jacobson LJ, Miller BI, Hathaway WE, Manco-Johnson MJ. 2003. A new euglobulin clot lysis assay for global fibrinolysis. Thromb. Res. 112: 329-337. https://doi.org/10.1016/j.thromres.2004.01.001
  33. Flemmig M, Melzig MF. 2012. Serine-proteases as plasminogen activators in terms of fibrinolysis. J. Pharm. Pharmacol. 64: 1025-1039. https://doi.org/10.1111/j.2042-7158.2012.01457.x
  34. Sumi H, Hamada H, Tsushima H, Mihara H, Muraki H. 1987. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet. Experientia 43: 1110-1111. https://doi.org/10.1007/BF01956052
  35. Peng Y, Yang X-J, Xiao L, Zhang Y-Z. 2004. Cloning and expression of a fibrinolytic enzyme (subtilisin DFE) gene from Bacillus amyloliquefaciens DC-4 in Bacillus subtilis. Res. Microbiol. 155: 167-173. https://doi.org/10.1016/j.resmic.2003.10.004
  36. Fujita M, Nomura K, Hong K, Ito Y, Asada A, Nishimuro S. 1993. Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Japan. Biochem. Biophys. Res. Commun. 197: 1340-1347. https://doi.org/10.1006/bbrc.1993.2624
  37. Kim W, Choi K, Kim Y, Park H, Choi J, Lee Y, et al. 1996. Purification and characterization of a fibrinolytic enzyme produced from Bacillus sp. strain CK 11-4 screened from Chungkook-Jang. Appl. Environ. Microbiol. 62: 2482-2488. https://doi.org/10.1128/aem.62.7.2482-2488.1996
  38. Kim SH, Choi NS. 2000. Purification and characterization of subtilisin DJ-4 secreted by Bacillus sp. strain DJ-4 screened from Doen-Jang. Biosci. Biotechnol. Biochem. 64: 1722-1725. https://doi.org/10.1271/bbb.64.1722
  39. Peng Y, Huang Q, Zhang RH, Zhang YZ. 2003. Purification and characterization of a fibrinolytic enzyme produced by Bacillus amyloliquefaciens DC-4 screened from douchi, a traditional Chinese soybean food. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 134: 45-52. https://doi.org/10.1016/S1096-4959(02)00183-5
  40. Jeong YK, Park JU, Baek H, Park SH, Kong IS, Kim DW, et al. 2001. Purification and biochemical characterization of a fibrinolytic enzyme from Bacillus subtilis BK-17. World J. Microbiol. Biotechnol. 17: 89-92. https://doi.org/10.1023/A:1016685411809
  41. Urano T, Ihara H, Umemura K, Suzuki Y, Oike M, Akita S, et al. 2001. The Profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis cleaves and inactivates plasminogen activator inhibitor type 1. J. Biol. Chem. 276: 24690-24696. https://doi.org/10.1074/jbc.M101751200
  42. Kim H, Kim G, Kim D, Choi W, Park S, Jeong Y, et al. 1997. Purification and characterization of a novel fibrinolytic enzyme from Bacillus sp. KA38 originated from fermented fish. J. Ferment. Bioeng. 84: 307-312. https://doi.org/10.1016/S0922-338X(97)89249-5
  43. Lee SK, Bae DH, Kwon TJ, Lee SB, Lee HH, Park JH, et al. 2001. Purification and characterization of a fibrinolytic enzyme from Bacillus sp. KDO-13 isolated from soybean paste. J. Microbiol. Biotechnol. 11: 845-852.
  44. Ko JH, Yan JP, Zhu L, Qi YP. 2004. Identification of two novel fibrinolytic enzymes from Bacillus subtilis QK02. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 137: 65-74. https://doi.org/10.1016/j.cca.2003.11.008
  45. Choi NS, Yoo KH, Hahm JH, Yoon KS, Chang KT, Hyun BH, et al. 2005. Purification and characterization of a new peptidase, bacillopeptidase DJ-2, having fibrinolytic activity: produced by Bacillus sp. DJ-2 from Doen-Jang. J. Microbiol. Biotechnol. 15: 72-79.
  46. Standeven KF, Carter AM, Grant PJ, Weisel JW, Chernysh I, Masova L, et al. 2007. Functional analysis of fibrin γ-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness. Blood 110: 902-907.
  47. Kim J-S, Kim J-E, Choi B-S, Park S-E, Sapkota K, Kim S, et al. 2008. Purification and characterization of fibrinolytic metalloprotease from Perenniporia fraxinea mycelia. Mycol. Res. 112: 990-998. https://doi.org/10.1016/j.mycres.2008.01.029
  48. Lu F, Lu Z, Bie X, Yao Z, Wang Y, Lu Y, et al. 2010. Purification and characterization of a novel anticoagulant and fibrinolytic enzyme produced by endophytic bacterium Paenibacillus polymyxa EJS-3. Thromb. Res. 126: e349-355. https://doi.org/10.1016/j.thromres.2010.08.003
  49. Cha W-S, Park S-S, Kim S-J, Choi D. 2010. Biochemical and enzymatic properties of a fibrinolytic enzyme from Pleurotus eryngii cultivated under solid-state conditions using corn cob. Bioresour. Technol. 101: 6475-6481. https://doi.org/10.1016/j.biortech.2010.02.048
  50. Deng Z, Wang S, Li Q, Ji X, Zhang L, Hong M. 2010. Purification and characterization of a novel fibrinolytic enzyme from the polychaete, Neanthes japonica (Iznka). Bioresour. Technol. 101: 1954-1960. https://doi.org/10.1016/j.biortech.2009.10.014
  51. Choi D, Cha W-S, Park N, Kim H-W, Lee JH, Park JS, et al. 2011. Purification and characterization of a novel fibrinolytic enzyme from fruiting bodies of Korean Cordyceps militaris. Bioresour. Technol. 102: 3279-3285. https://doi.org/10.1016/j.biortech.2010.10.002
  52. Lee S-Y, Kim J-S, Kim J-E, Sapkota K, Shen M-H, Kim S, et al. 2005. Purification and characterization of fibrinolytic enzyme from cultured mycelia of Armillaria mellea. Protein Expr. Purif. 43: 10-17. https://doi.org/10.1016/j.pep.2005.05.004
  53. Wang CT, Ji BP, Li B, Nout R, Li PL, Ji H, et al. 2006. Purification and characterization of a fibrinolytic enzyme of Bacillus subtilis DC33, isolated from Chinese traditional Douchi. J. Ind. Microbiol. Biotechnol. 33: 750-758. https://doi.org/10.1007/s10295-006-0111-6
  54. Simkhada JR, Mander P, Cho SS, Yoo JC. 2010. A novel fibrinolytic protease from Streptomyces sp. CS684. Process Biochem. 45: 88-93. https://doi.org/10.1016/j.procbio.2009.08.010
  55. Chen H, McGowan EM, Ren N, Lal S, Nassif N, Shad-Kaneez F, et al. 2018. Nattokinase: A promising alternative in prevention and treatment of cardiovascular diseases. Biomark. Insights. 13: 1177271918785130.
  56. Chang Y-Y, Liu J-S, Lai S-L, Wu H-S, Lan M-Y. 2008. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern. Med. 47: 467-469. https://doi.org/10.2169/internalmedicine.47.0620
  57. Milner M, Makise K. 2002. Natto and its active ingredient nattokinase: A potent and safe thrombolytic agent. Altern. Complement. Ther. 8: 157-164. https://doi.org/10.1089/107628002760091001
  58. Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA, Fumanelli M, et al. 2002. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab. Anim. 36: 20-42. https://doi.org/10.1258/0023677021911740

Cited by

  1. Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications vol.13, pp.11, 2021, https://doi.org/10.3390/pharmaceutics13111880